Previous Article | Next Article ![]()
Journal of Bacteriology, August 2002, p. 4500-4509, Vol. 184, No. 16
0021-9193/02/$04.00+0 DOI: 10.1128/JB.184.16.4500-4509.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Hans Wolf-Watz,2 and Åke Forsberg1,2*
Department of Medical Countermeasures, Division of NBC-Defense, Swedish Defense Research Agency, S-901 82 Umeå,1 Department of Molecular Biology, Umeå University, S-901 87 Umeå, Sweden2
Received 13 March 2002/ Accepted 17 May 2002
|
|
|---|
|
|
|---|
TTSSs are found in several gram-negative animal and plant pathogens (20, 39). The overall mechanism of secretion appears to be conserved in the different systems. Typically, 20 to 25 proteins are required to assemble a functional secretion system. Nine of these proteins are conserved not only in the TTSSs of different pathogens but also in the bacterial flagellar export apparatus (for reviews, see references 1, 20, and 25). For several animal pathogens, the type III secretion organelle, also referred to as the secreton, has been isolated and analyzed (5, 6, 21, 22, 40, 44). The basal body of this structure possesses two sets of rings resembling the flagellar basal body. The components common to the virulence associated and the flagellar TTSS are believed either to associate with the cytoplasmic face of the basal body-like structure or to form a pore in the inner membrane ring (15, 42). A common feature of secretons isolated so far is a needle-like structure that protrudes from the ring structure located in the outer membrane. This needle is required for secretion, suggesting that the combination of the basal portion and needle extension (needle complex) constitutes an intact secretion organelle (5, 6, 21, 22, 40, 44). In Yersinia spp. the needle-like structure is comprised of the YscF protein and localizes to the bacterial cell surface prior to eukaryotic cell contact (18; P. Edqvist, J. Olsson, M. Lavander, L. Sundberg, Å. Forsberg, H. Wolf-Watz, and S. Lloyd, unpublished data).
The proteins forming the actual secretion apparatus are believed to somehow identify the type III secretion substrates to enable their secretion through the basal body-like structure. One key protein in the export of flagellar components is FlhB, a membrane protein with a large cytoplasmic C-terminal domain (29, 30). YscU, the corresponding protein of the TTSS of Yersinia spp. has also been shown to localize to the cytoplasmic membrane (3). The flagellum is a tripartite organelle consisting of the membrane spanning basal body, the propulsive flagellar filament, and the hook which joins the two former (for reviews, see references 2 and 26). During flagellar assembly, one critical event is when the hook is completed and the secretion system switches from secreting hook components to filament components. FliK, a protein secreted by the flagellar secretion system during hook assembly, somehow senses when the hook is completed and communicates with the secretion system to switch the export specificity to flagellin (23, 28, 33, 45). As a consequence, fliK mutants have two distinct mutant phenotypes: they are disabled (i) in the terminating hook assembly and (ii) in the initiating filament assembly, leading to the formation of so-called "poly-hook" structures (17, 34, 43). Interestingly, extragenic suppressor mutants that allow secretion and assembly of filament-type substrates have been isolated and mapped to flhB, which indicates that FliK and FlhB interact to control the order in which flagellar components are secreted (23, 45). It has been suggested that FliK, upon the completion of hook assembly, switches the substrate specificity of the flagellar export apparatus by altering the conformation of FlhB in order to promote the export of the filament component, flagellin. Minamino and Macnab also demonstrated that FlhB is proteolytically cleaved at position proline-270 within a region of four amino acids, i.e., NPTH (Fig. 1), which is conserved in all FlhB/YscU homologues (31).
![]() View larger version (38K): [in a new window] |
FIG. 1. Schematic drawing of the structure of the homologous proteins YscU and FlhB adapted from the studies by Allaoui et al. (3) and Minamino and Macnab (31). Black numbers indicate amino acid positions of YscU, and numbers in italics (gray) represent those of FlhB. The sequence NPTH (amino acids 263 to 266 and amino acids 269 to 272) is conserved through the YscU/FlhB family and contains the proline-270 where FlhB has been shown to be cleaved (31).
|
We examined here the function of the YscU protein in the Yersinia type III secretion system. We demonstrate that YscU is cleaved at the same position, proline-264 (Fig. 1), as was previously shown for FlhB, which results in a C-terminal fragment of ca. 10 kDa. The different domains of YscU were found to influence Yop expression and secretion differently. High levels of full-length YscU resulted in lowered Yop expression, whereas expression of the C-terminal 10-kDa domain in a wild-type bacterial background instead resulted in increased Yop secretion. Deletion of the conserved four amino acids, NPTH (amino acids 263 to 266), rendered YscU nonfunctional in Yop secretion, and in this case the proteolysis occurred at a different position. Single substitutions of the conserved residues prevented cleavage of YscU, but the protein was still functional in secretion, which suggests that proteolytic cleavage of YscU is not essential for its function in the TTSS. Instead, it seems that the cleavage of YscU is essential for the survival of the bacteria, since the uncleaved form of YscU was highly toxic.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids used in this study
|
DNA methods. Preparation of plasmid DNA, restriction enzyme digests, separation by gel electrophoresis, ligation, and transformation of E. coli strains were performed according to standard methods (38). Certain DNA fragments were purified from agarose gels by using GeneClean Kit (Bio 101) or GeneElute Minus EtBr Spin Columns (Sigma). DNA sequencing reactions were performed by using the ThermoSequenase dye terminator cycle sequencing kit and analyzed with a SEQ4x4 sequencer (Amersham Pharmacia Biotech).
Sequence analysis. A similarity search of protein sequence databases was conducted by using the basic local alignment search tool (BLAST) server program with default parameters (4). The MegAlign program from DNASTAR with default parameters was used to perform protein alignments.
Construction of the yscU in-frame deletion strain.
The yscU in-frame deletion strain, YPIII(pIB75) was constructed as follows. A double PCR was performed with the primer pairs YscU3/YscU4 and YscU5/YscU6 (Table 2), respectively, by using the virulence plasmid pIB102 as a template, rendering one fragment from the upstream and one from the downstream region of yscU. These fragments were ligated by PCR with the primer pair YscU3/YscU6. The resulting PCR product was digested with XbaI and SacI and cloned into the same restriction sites of pDM4, yielding plasmid pLS13. This plasmid was transformed into E. coli S17-1
pir, from which it was introduced by conjugation into the recipient Yersinia strain YPIII(pIB102). Clones with pLS13 integrated into pIB102 by a single recombinant event were selected on YSAB plates containing kanamycin and chloramphenicol. To select for bacteria having lost the suicide vector sacB-dependent sucrose sensitivity (27) was employed. Sucrose-resistant colonies were PCR amplified to confirm the presence of the deletion. The resulting strain, YPIII(pIB75), carries a yscU in-frame deletion of amino acids 25 to 329.
|
View this table: [in a new window] |
TABLE 2. Primer sequencesa
|
Amplified DNA fragments were ligated with the linearized pCR2.1-TOPO cloning vector and transformed into E. coli TOP10 One Shot chemically competent cells, all according to the manufacturer's instructions (Invitrogen). Plasmids were purified from TOP10 cells and restricted with EcoRI and PstI. The excised fragments were purified from a 1% SeaKem GTG agarose gel by using GeneClean Kit (Bio 101). Ligation with pMMB66EH, restricted with EcoRI and PstI, was followed by electroporation into E. coli S17-1
pir. A positive clone was used for introduction of the constructs into the recipient Yersinia strains by conjugation. Transformants were plated onto YSAB plates selecting for both the virulence plasmid and pMMB66EH. Positive clones were identified by PCR, plasmid preparation, and restriction of these plasmids with PstI and EcoRI.
Construction of mutations in the cytoplasmic domain of YscU. The template used for deletion of the four amino acid conserved site, NPTH (amino acids 263 to 266), was pLS21 (Table 1). To introduce substitutions at residues N263, P264, and T265 the previously described plasmid pPE33 (Table 1; Edqvist et al.) was used as a template. The site-directed mutagenesis was carried out according to the procedures in the QuickChange Mutagenesis Kit (Stratagene). The mutagenic oligonucleotides used (Table 2) were as follows: NPTH deletion PE34/SL99, N263A mutation PE73/PE102, P264A mutation PE74/PE103, and T265A mutation PE75/PE104, resulting in the construction of plasmids pPE40, pPE41, pPE42, and pPE43, respectively. The mutant versions of yscU were Flag tagged and introduced into pMMB66EH by using the pPE40-43 plasmids as templates in PCR with primers YscU19 and YscU23, essentially as described above when Flag tagging the wild-type yscU. The resulting plasmids were denoted pML16, pML17, pML18, and pML19, respectively (Table 1).
Analysis of LCR phenotypes: MOX test. The strains tested were grown over night and then diluted in 0.9% NaCl. The serial dilutions were spread on Ca2+ containing or MOX plates. The plates were incubated at 26 or 37°C overnight. The number of colonies was counted for determination of growth phenotypes.
Definition of growth phenotypes. Strains unable to grow at 37°C without the addition of Ca2+ are defined as calcium dependent, which is the wild-type growth phenotype for Y. pseudotuberculosis. Calcium-independent mutants grow at 37°C irrespective of the Ca2+ concentration, a phenotype usually coupled to impaired secretion. A strain unable to grow at 37°C is defined as temperature sensitive and usually secretes Yops irrespective of calcium.
Viable count. Strains expressing YscU variants that were not proteolytically cleaved, i.e., N263A, P264A, or T265A, showed a decreased growth rate in liquid culture. To further investigate the growth deficiency viable count in the absence and presence of IPTG (isopropyl-ß-D-thiogalactopyranoside) was performed. The strains containing the different YscU variants were cultured overnight and then diluted in 0.9% NaCl. The serial dilutions were spread on BAB plates with added antibiotics, as well as plates with both antibiotics and 0.4 mM IPTG. Colony formation was monitored for 3 days, and the colonies were counted for calculation of the viability after 3 days of incubation.
Yop secretion assay. Overnight cultures of Yersinia strains grown at 26°C were diluted (1:10) in fresh media (BHI plus Ca2+or BHI minus Ca2+) and grown for 1 h at 26°C prior to a temperature shift to 37°C and growth for an additional 3 h. For induction of the tac promoter, IPTG was added to a final concentration of 0.4 mM. After measuring the optical density at 600 nm (OD600), the bacteria were harvested by centrifugation and dissolved in 400 µl of 2x sodium dodecyl sulfate (SDS) sample buffer. The culture supernatants were filtrated through a 0.45-µm (pore-size) filter to rid them of any remaining bacteria. Then, 400 µl of the supernatants was removed and diluted in 400 µl of 2x SDS sample buffer, to be separated by SDS-polyacrylamide gel electrophoresis (PAGE) and analyzed by enhanced chemiluminescence (ECL) Western blot as described below. The rest of the supernatant proteins were precipitated with 10% trichloroacetic acid and collected by centrifugation. The proteins were dissolved in 500 µl of 2% SDS at 37°C, precipitated with acetone, and pelleted again by centrifugation. The secreted proteins were finally dissolved in 400 µl of 2x SDS sample buffer to be separated by SDS-PAGE and visualized by Coomassie brilliant blue staining.
Immunoblotting. Samples were routinely boiled for 5 min prior to separation by denaturating SDS-PAGE (12 to 15% [wt/vol] acrylamide). Electroblotting of proteins to Immobilon-P Transfer Membranes (Millipore) was performed by using Trans-Blot Semi-Dry transfer cell (Bio-Rad) and buffers as described by Laemmli (24). Membranes were blocked overnight in Tris-buffered saline (TBS) with 5% nonfat dry milk.
Yop proteins were detected with a polyclonal rabbit antiserum raised against the secreted Yops. The Flag-tagged derivatives of YscU were detected with anti-Flag M2 monoclonal mouse antibodies (Sigma).
After three 10-min washes in TBS with 0.1% Tween (TBS-T), the membranes were probed with a secondary antibody conjugated to horseradish peroxidase and directed against mouse or rabbit (Amersham Pharmacia Biotech). Visualization of the proteins was performed with ECL detection (Amersham Pharmacia Biotech).
Purification of Flag-tagged constructs for N-terminal sequencing. To establish the locus for cleavage of YscU, Flag-tagged constructs were used. Overnight cultures of the Y. pseudotuberculosis strains YPIII(pIB75+pML13) and YPIII(pIB102+pML12) were diluted 1:20 in 50 ml of fresh medium and cultured at 26°C to an OD600 of 0.5. Expression of the YscU derivatives was induced by addition of 0.4 mM IPTG, and the bacteria were grown for an additional 3 h at 37°C. Cells were harvested by centrifugation, and the pellet was dissolved in 5 ml of TBS (pH 7.4) with 0.1 mM phenylmethylsulfonyl fluoride. Bacteria were lysed by sonication and, after pelleting the debris by centrifugation, the supernatant was incubated overnight with anti-Flag M2 affinity gel beads (Sigma) at 4°C. Upon removal of the supernatant, the gel beads were washed repeatedly with TBS (pH 7.4). The Flag fusion proteins were eluted by competitive elution with 150-µl volume aliquots of a solution containing 100 µg of Flag peptide/ml in TBS (pH 7.4). The proteins in the resulting eluates were separated by SDS-PAGE and blotted to polyvinylidene difluoride Immobilon-P transfer membranes (Millipore). Upon Coomassie brilliant blue staining, the YscU fragments were excised and N-terminally sequenced by Per-Ingvar Ohlsson of the Department of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden.
Preparation of YscU antiserum. YPIII(pIB102) genomic DNA was PCR amplified with the primer pair PE9/PE10. The resulting PCR product, which consists of codons 202 to 354 (encoding the cytoplasmic domain of YscU), was digested with NdeI and XhoI and cloned into the same sites of the pET-22B vector. This places a six-histidine tag on the C terminus of YscU. This construct, pPE5, was transformed into E. coli BL21(DE3). Cells were grown overnight at 37°C in LB containing 100 µg of carbenicillin ml-1. The cultures were diluted 100-fold into 500 ml of fresh medium and were grown to an OD600 of 0.5. Expression of the YscU cytoplasmic domain was induced by the addition of 0.4 mM IPTG, and the cells were grown for an additional 3 h at 37°C. Cells were then centrifuged and resuspended in 10 ml of lysis buffer (50 mM Tris, pH 8.0; 25 mM NaCl; 0.1 mM EDTA). Lysozyme was added to a final concentration of 0.1 mg ml-1, and the cells were left on ice for 30 min. Cells were then lysed by sonication and were centrifuged for 20 min at 20,800 x g to pellet unlysed cells and insoluble material. The insoluble pellet, containing the cytoplasmic domain of YscU, was washed with 1% Triton X-100-1 mM EDTA and then resuspended in lysis buffer containing 8 M urea. The resuspension was centrifuged as described above to remove insoluble material, and the soluble supernatant was passed over a nickel-nitrilotriacetic acid column (Qiagen). The column was washed with 10 volumes of lysis buffer containing 8 M urea, and the cytoplasmic domain of YscU was eluted stepwise with lysis buffer-urea containing increasing concentrations of imidazole. Purified YscU was diluted to 4 M urea and antibodies against purified YscU were generated in rabbits by AgriSera AB, Vännäs, Sweden.
|
|
|---|
![]() View larger version (107K): [in a new window] |
FIG. 2. Yop secretion is blocked and Yop expression diminished in the yscU-null mutant. Yop expression and secretion was analyzed in the yscU-null mutant YPIII(pIB75) and the wild-type strain YPIII(pIB102) by ECL Western blot, with polyclonal antiserum raised against the secreted Yops whole-cell fractions (A) and supernatant fractions (B), respectively. The bacteria were cultured in BHI medium depleted for calcium at 37°C. For details, see Materials and Methods. Molecular mass markers are shown to the left in kilodaltons.
|
![]() View larger version (87K): [in a new window] |
FIG. 3. Transcomplementation of the yscU null mutant strain. ECL Western blot, with polyclonal antiserum raised against the secreted Yops was used to study complementation of the yscU-null mutant YPIII(pIB75) with pLS21 or pML13 in trans expressing wild-type or a Flag-tagged variant of YscU, respectively, whole-cell fractions (A) and supernatant fractions (B), respectively. The bacteria were cultured in BHI lacking calcium at 37°C, with or without 0.4 mM IPTG, as implied in the figure. Molecular mass markers are shown to the left in kilodaltons.
|
![]() View larger version (73K): [in a new window] |
FIG. 4. The cytoplasmic domain of YscU stimulates Yop secretion. Secretion of Yops by strain YPIII(pIB102) with pML14 or pML11 expressing the C-terminal cytoplasmic domain of YscU, amino acids 264 to 354 or amino acids 211 to 354, respectively. Separation of proteins in the supernatant fractions was performed by SDS-PAGE, followed by Coomassie brilliant blue staining. The bacteria were cultured in BHI lacking calcium at 37°C, with or without 0.4 mM IPTG, as indicated in the figure. Molecular mass markers are shown to the left in kilodaltons.
|
![]() View larger version (35K): [in a new window] |
FIG. 5. The cytoplasmic domain of YscU is proteolytically cleaved at proline-264. The cleavage pattern of full-length YscU was analyzed in the yscU-null mutant strain YPIII(pIB75) with pLS21 or pML13 expressing a wild-type or a Flag-tagged form of YscU, respectively. For analysis of the cleavage of the cytoplasmic domain (amino acids 211 to 354) of the protein, the wild-type strain YPIII(pIB102) with pML11 or pML12 was utilized, expressing a nontagged and a Flag-tagged variant of this domain of YscU, respectively. Proteins were visualized by using ECL Western blot to whole-cell fractions with antiserum raised against the cytoplasmic domain of YscU (amino acids 202 to 354) (A) or monoclonal antibodies directed against the Flag epitope (B). The different forms of YscU indicated in the figure are as follows: the full-length protein (amino acids 1 to 354), the N-terminal cleavage product (amino acids 1 to 263), and the C-terminal cleavage product (amino acids 264 to 354). The bacteria were cultured in BHI depleted for calcium at 37°C, with or without 0.4 mM IPTG, as indicated in the figure. The thinner arrow points to a nonspecific protein band recognized by the anti Flag-antibodies, which also appears in negative controls, i.e., in Yersinia strains that do not carry Flag-tagged YscU constructs. Molecular mass markers are shown to the left in kilodaltons.
|
![]() View larger version (56K): [in a new window] |
FIG. 6. The proteolytic cleavage of YscU is independent of a functional TTSS. ECL Western blot with monoclonal antibodies directed against the Flag epitope was employed to visualize the cleavage of YscU in whole-cell fractions in different bacteria: E. coli K-12 strain S17-1 pir, the plasmid-cured strain YPIII, and the yscU-null mutant YPIII(pIB75), all containing pML13 expressing full-length YscU tailed with a Flag tag. The different forms of YscU indicated in the figure are the full-length protein YscU (amino acids 1 to 354) and the C-terminal cleavage product YscU (amino acids 264 to 354). The thinner arrow points to a protein band recognized by the Flag antibodies that appears also in negative controls, i.e., Yersinia strains where no Flag-tagged construct is present. The Yersinia strains were cultured at 37°C in calcium-depleted medium, and the E. coli strain was grown in LB at 37°C; all cultures were supplemented with 0.4 mM IPTG. Molecular mass markers are shown to the left in kilodaltons.
|
NPTH deletion and wild-type YscU were expressed in trans in the yscU mutant strain. Bacteria were grown at 37°C in medium lacking calcium, which normally induces Yop secretion. Western blots of cell pellet fractions revealed that the
NPTH mutant protein was also cleaved, but in this case the C-terminal fragment was larger than that observed for wild-type YscU (Fig. 7). This suggests that the cytoplasmic domains of the
NPTH mutant have an altered conformation. Significantly, no Yop secretion was seen in the
NPTH mutant (Fig. 8C), indicating that the conformation and correct cleavage of the cytoplasmic domains are critical for the function of YscU in type III secretion by Yersinia.
![]() View larger version (55K): [in a new window] |
FIG. 7. The YscU NPTH mutant shows a different cleavage pattern compared to the wild-type protein. The C-terminally Flag-tagged proteins YscU or YscU NPTH were expressed in the yscU-null mutant strain YPIII(pIB75) from plasmids pML13 and pML16, respectively. The cleaved forms of YscU were visualized by ECL Western blot with monoclonal antibodies directed against the Flag epitope. The different forms of YscU indicated in the figure are as follows: the full-length protein YscU (amino acids 1 to 354), the C-terminal cleavage product, YscU (amino acids 264 to 354), and the ca 15-kDa C-terminal fragment of the NPTH mutant protein which is indicated with an asterisk. The thinner arrows point to two nonspecific bands that also appear in negative controls with Yersinia strains that do not carry any Flag-tagged YscU constructs. The bacteria were cultured in BHI depleted of calcium at 37°C, with or without 0.4 mM IPTG, as indicated in the figure. Molecular mass markers are shown to the left in kilodaltons.
|
![]() View larger version (60K): [in a new window] |
FIG. 8. YscU cleavage is not required for functional Yop secretion. Four forms of YscU with different mutations ( NPTH, N263A, P264A, and T265A) were expressed from plasmids pML16, pML17, pML18, or pML19, respectively, in the yscU-null mutant strain YPIII(pIB75) and compared to the wild-type strain YPIII(pIB102). (A) ECL Western blot with monoclonal antibodies directed against the Flag epitope to visualize the Flag epitope containing fragments of YscU. The different forms of YscU indicated are, the full-length protein YscU (amino acids 1 to 354), the C-terminal cleavage product, YscU (amino acids 264 to 354). The thinner arrows point to two nonspecific bands which also appear in negative controls with Yersinia strains that do not carry any Flag-tagged constructs. ECL Western blot with polyclonal antiserum raised against the secreted Yops to analyze Yop expression and secretion was performed on whole-cell fractions (B) and supernatant fractions (C), respectively. The bacteria were cultured in BHI lacking calcium at 37°C, with or without 0.4 mM IPTG, as indicated in the figure. Molecular mass markers are shown to the left in kilodaltons.
|
NPTH mutant protein in trans, whereas already low expression levels of the point mutated YscU variants affected growth rate. Colonies of strain YPIII(pIB75) expressing the single-site-mutated proteins were not visible until after 2 days of growth compared to 1 day for the strain expressing wild-type YscU. This shows that the expression of these variants of YscU, which retained function in Yop secretion but could not be cleaved, was highly toxic. Therefore, one important role of cleavage of YscU is to prevent the toxic affect of the full-length YscU protein on the bacterial cell. |
|
|---|
In this work we have studied the role of the FlhB homologue YscU of Y. pseudotuberculosis in type III secretion of Yop effector proteins. We confirm that YscU, as previously shown in Y. enterocolitica (3), is essential for Yop secretion in Y. pseudotuberculosis. A yscU-null mutant was unable to secrete Yops during inducing conditions in vitro, and the mutant also showed decreased Yop expression compared to the wild-type strain. This is a common phenomenon in type III secretion mutants and is believed to be the result of a feedback inhibition mechanism (11).
Only low levels of YscU were required to fully restore Yop expression and secretion when the yscU mutant was transcomplemented, whereas higher expression levels of YscU resulted in lowered Yop expression as well as secretion. This initial observation suggested that YscU, like FlhB, can influence protein secretion levels. Previous work by Allaoui et al. (3) had revealed that a large C-terminal domain of YscU localizes to the cytoplasm, and hence we hypothesized that it could be involved in controlling Yop secretion. In line with this, overexpression of the C-terminal cytoplasmic domain of YscU (amino acids 211 to 354) in the wild-type strain resulted in elevated Yop secretion. Importantly, Yop expression levels were not affected, indicating that the C-terminal cytoplasmic part of YscU preferentially acts at the level of secretion.
The YscU/FlhB protein family is one of the most highly conserved of the TTSSs, and the homologies of the cytoplasmic domains are particularly high. Aligning the proteins of the YscU/FlhB family reveals the presence of a four-amino-acid sequence in the middle of the C-terminal cytoplasmic domain, NPTH, which is conserved among the FlhB/YscU homologues. Interestingly, it was recently shown that FlhB was unstable when expressed in E. coli and that proteolytic cleavage occurred at position Pro-270 within the conserved NPTH sequence, yielding a 10-kDa C-terminal fragment (31). Using a C-terminally Flag-tagged variant of YscU, we could establish that YscU was also cleaved at the corresponding site, Pro-264, during conditions promoting Yop secretion. Cleavage at the same position also occurred when the Flag-tagged C-terminal cytoplasmic domain YscU (amino acids 211 to 354) was expressed in the wild-type strain. This result, together with our observation that overexpression of the whole C-terminal cytoplasmic portion of YscU leads to increased secretion, suggested that it might be the C-terminal cleavage product YscU (amino acids 264 to 354) that promotes Yop secretion. By expressing this variant of YscU (amino acids 264 to 354) in trans in the wild-type strain we could show that the 10-kDa C-terminal fragment resulting from the proteolytic cleavage is biologically active and promotes elevated Yop secretion.
These data strongly argued that the observed cleavage at Pro-264 was important for YscU function in type III secretion. However, YscU cleavage is not mediated by other components directly involved in TTSS, since efficient cleavage also occurred in a Y. pseudotuberculosis strain lacking the entire TTSS, as well as in E. coli K-12 lacking a functional TTSS. This indicated that the cleavage per se is not a key regulatory event in induction and assembly of TTSS.
To further investigate the significance of YscU proteolysis in relation to Yop secretion, we constructed a variant of YscU where the conserved residues NPTH (amino acids 263 to 266) were deleted. Deletion of these four amino acids resulted in the loss of YscU function in Yop secretion, and YscU was now cleaved at a different position, yielding an approximately 15-kDa C-terminal fragment. Minamino and Macnab (31) recently showed that the 10-kDa cytoplasmic domain of FlhB resulting from the proteolytic cleavage at Pro-270 interacted with the other cytoplasmic domain, corresponding to YscU amino acids 211 to 263 (Fig. 1). Since proteolysis of the
NPTH mutant appears to result in disruption of the domain between amino acids 211 and 263, it would abolish any potential interaction between the two cytoplasmic domains of YscU. This could then explain why the
NPTH mutant is nonfunctional in Yop secretion. Furthermore, the different cleavage pattern observed for the
NPTH mutant indicates that deletion of the conserved four-amino-acid motif affects the conformation of the cytoplasmic domain of YscU, which in turn also could render the protein nonfunctional.
Interestingly, substitutions of individual amino acids of the NPTH motif of YscU, i.e., N263A, P264A, and T265A, resulted in YscU derivatives that were not cleaved, demonstrating that these three residues are critical for cleavage to occur. However, when expressed at low levels, these YscU variants complemented the yscU-null mutant strain with respect to type III secretion. Thus, specific cleavage at the conserved amino acid residue was not, as initially anticipated, required for YscU function in Yop secretion. Instead, induction of higher levels of transcription of these uncleaved but functional variants of YscU was toxic not only to Y. pseudotuberculosis but also to E. coli K-12. Thus, for functional type III secretion the conformation of the cytoplasmic domain of YscU appears to be critical, whereas the specific cleavage at the conserved proline-264 is required for survival of the bacterium since the uncleaved functional form of YscU is highly toxic to the bacterium.
Cleavage of YscU and FlhB occurs also in E. coli (31), and we show here that cleavage occurs in a strain lacking TTSS. This indicates that the protease promoting cleavage could be common to most gram-negative bacteria. A conserved protease might be essential to these bacteria, and the toxic effect seen during high expression levels of the YscU variants (N263A, P264A, and T265A) could be the result of out-titration of the protease; therefore, the toxic effect would be indirect and not directly dependent on the expression of the noncleavable variants of YscU. However, cleavage was almost complete also when the wild-type form of YscU was expressed at high levels and, in addition, the toxic effect on the bacterial cell was also seen at low expression levels of the different YscU variants. Therefore, we favor the idea that the toxic effect is directly mediated by the YscU variants that were not cleaved and was the result of a different conformation of these proteins.
During the sequential assembly of the bacterial flagellum a key event is the switch from export of hook-rod substrates to filamental substrates. In this event, FlhB and FliK play a central role. fliK mutants display a poly-hook phenotype, i.e., they are disabled in the step where export of hook-rod proteins normally is exchanged for export of filament protein (17, 34, 43). The poly-hook phenotype of a fliK mutant can be suppressed by second-site mutations in the cytoplasmic domain of FlhB (23, 45). This clearly suggests a mechanism where FlhB and FliK, directly or indirectly, interact to somehow control secretion of the different substrates.
Recent work (Edqvist et al.) has demonstrated that this role in the regulation of the type III system is shared by the FlhB homologue in Y. pseudotuberculosis TTSS, YscU, and the protein corresponding to FliK, YscP. A yscP mutant exported higher levels of the needle component YscF to the bacterial surface and was impaired in Yop secretion, thus indicating that this mutant is deficient in the switch from assembly of the substrates that constitute the type III export machinery to secretion of Yop proteins. In analogy to the flagellar system, second-site mutations in the C-terminal cytoplasmic domain of YscU suppress the phenotype of the yscP mutant (Edqvist et al.).
Interestingly, YscP shows low levels of homology to InvJ of Salmonella enterica serovar Typhimurium, which has been found by Galan and coworkers to control the length of the needle part of the type III secreton in Salmonella (22). This suggests that different pathogens share a common mechanism of TTSS whereby a critical step involves a switching mechanism from secreting needle components to effector proteins. The cytoplasmic part of FlhB resulting from specific cleavage has been shown to interact with secretion substrates including rod-hook, filament proteins, as well as FliK (31, 32). Therefore, it is conceivable that YscU also interacts with the type III secretion substrates YscF, Yops, and YscP. As suggested for FlhB, it is likely that initially the affinity of YscU is highest for the rod-hook analogue YscF but that upon needle completion conformational changes in YscU are induced by protein-protein interactions, possibly via YscP, to increase the affinity of YscU for Yop substrates to allow switching to effector protein secretion.
Present address: Department of Pediatrics, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»